Symbiox® Listed in Catalog of Medicine covered by national medical insurance system
Symbiox® Listed in Catalog of Medicine covered by national medical insurance system
First in class drug Symbiox ® obtained registration certificate
Mr. Zhang Yongming became controlling shareholder
Guanhao acquired Beijing Wenfeng Tianji Pharma, and Guangdong Zhonghao Pharma.
Guanhao acquired Zhuhai Sunny Medical Device Co., Ltd.
Guanhao and Peking University co-founded Bei Hao Research Stem Cell and Regenerative Research Institute
Guanhao began industrialization of immunocyte storage technology
Founded "Guangdong Guanhao Life and Health Industry Park"
Listed on the GEM board of China Shenzhen Stock Exchange
Awarded by the National Development and Reform Commission for the Construction of the State’s High-tech Industrialization Demonstration Project
Awarded by the National Development and Reform Commission for the construction of the National Engineering Laboratory for Regenerative Implantable Medical Devices
Obtained Approval for first product NormalGEN® dura repair patch
020-32052806